Benzinga | Aug 11, 2021 01:45PM EDT

Quest Diagnostics, eMed Team Up To Offer COVID-19 Rapid Antigen Testing At Workplaces

* Telehealth company eMed and Quest Diagnostics Inc (NYSE:DGX) have collaborated for clinician-guided rapid antigen testing for COVID-19 in workplaces.

* Through the collaboration, the two companies will leverage the BinaxNOW COVID-19 Ag Card Home Test, a self-administered nasal swab antigen test that provides results in 15 minutes.

* An eMed Certified Guide will virtually supervise the testing process, confirm employee identity, oversee proper sample collection, and authenticate results during a telehealth visit.

* Individuals will receive their validated results via a digital health pass on their smart device, and employers will have access to a portal with consolidated employee test results.

* Price Action: DGX shares are up 0.16% at $148.81 during the market session on the last check Wednesday.